Can-Fite BioPharma (CANF) Stock Chart & Stock Price History $1.07 -0.01 (-0.93%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.07 0.00 (0.00%) As of 06/13/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Can-Fite BioPharma Stock Price Performance The Can-Fite BioPharma (CANF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.06%, with a year-to-date return of -34.15%. In the past month, the stock has increased 3.38%, reflecting recent market activity. As of the latest close, Can-Fite BioPharma traded at $1.07 with a market cap of $3.79 million and volume of 38,950 shares. Five years ago, the stock traded at a split-adjusted price of $16.70, representing a 93.59% decrease over that period. At the time, it had a market cap of $21.68 million and a volume of 174,020 shares. Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.60%1 Month Performance+3.38%3 Month Performance-34.36%Year-To-Date Performance-34.15%1 Year Performance-68.06%5 Year Performance-93.59% CANF Stock Chart for Saturday, June, 14, 2025 CANF Chart by TradingView Can-Fite BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$1.08$1.07-0.93%$1.09$1.0538,950 shs$3.79 million06/12/2025$1.10$1.08-1.37%$1.11$1.0765,816 shs$3.82 million06/11/2025$1.11$1.10-1.35%$1.12$1.0875,914 shs$3.88 million06/10/2025$1.11$1.11$1.12$1.0851,026 shs$3.93 million06/09/2025$1.10$1.11+1.37%$1.12$1.0851,288 shs$3.93 million06/06/2025$1.08$1.10+1.39%$1.10$1.0874,062 shs$3.88 million06/05/2025$1.11$1.08-2.70%$1.11$1.0744,263 shs$3.82 million06/04/2025$1.10$1.11+0.91%$1.11$1.0962,688 shs$3.93 million06/03/2025$1.10$1.10+0.46%$1.12$1.0956,503 shs$3.89 million06/02/2025$1.08$1.10+1.86%$1.10$1.0740,931 shs$3.88 million Get the Latest News and Ratings for CANF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$1.08$1.08-0.46%$1.08$1.0652,388 shs$3.81 million05/29/2025$1.07$1.08+1.41%$1.09$1.0676,701 shs$3.82 million05/28/2025$1.07$1.07$1.07$1.0561,541 shs$3.77 million05/27/2025$1.04$1.07+2.50%$1.07$1.0356,121 shs$3.77 million05/26/2025$1.04$1.04$1.04$1.0332,608 shs$3.68 million05/23/2025$1.04$1.04-0.10%$1.04$1.0332,608 shs$3.68 million05/22/2025$1.04$1.04+0.39%$1.05$1.0318,529 shs$3.68 million05/21/2025$1.06$1.04-1.80%$1.06$1.0350,420 shs$3.67 million05/20/2025$1.05$1.06+0.96%$1.07$1.0382,282 shs$3.74 million05/19/2025$1.05$1.05-0.48%$1.05$1.0265,463 shs$3.70 million05/16/2025$1.05$1.05+0.48%$1.08$1.0358,177 shs$3.72 million05/15/2025$1.04$1.05+0.97%$1.05$1.0335,638 shs$3.70 million05/14/2025$1.09$1.04-5.05%$1.09$0.98228,421 shs$3.66 million05/13/2025$1.10$1.09-0.91%$1.10$1.06103,231 shs$3.86 million Related Companies Rallybio Stock Price Chart NKGen Biotech Stock Price Chart iBio Stock Price Chart Abpro Stock Price Chart NextCure Stock Price Chart ProPhase Labs Stock Price Chart Synlogic Stock Price Chart MEI Pharma Stock Price Chart VYNE Therapeutics Stock Price Chart TherapeuticsMD Stock Price Chart Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CANF) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can-Fite BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
